Jim Cramer's Pfizer Dilemma: High Yield Can't Mask Growth Concerns
CNBC's Jim Cramer includes Pfizer in his weekly game plan but voices unease over the pharmaceutical giant's pipeline, questioning where its next blockbuster drug will come from despite an attractive dividend yield.